section name header

Diagnosis

Diagnosis-icon.jpg Differential Diagnosis

Insect (Arthropod) Bite Reactions (Sometimes Referred to as Papular Urticaria [see Discussion in Chapter 29: Bites, Stings, and Infestations])
  • Reactions to insect bites may be indistinguishable from ordinary hives.

  • Bites are generally seen on exposed areas.

  • They may have a central punctum and crust; they may also blister.

  • Individual lesions may last more than 24 hours.

Erythema Multiforme Minor (see Discussion below)
  • Lesions are targetoid.

  • Last more than 24 hours.

  • Generally nonpruritic.

Erythema Migrans (Acute Lyme Disease [see Discussion in Chapter 29: Bites, Stings, and Infestations])
  • May be indistinguishable from urticaria.

  • Lesions are usually solitary, annular, and target-like.

  • Lesions may last more than 24 hours.

  • Lesions are generally nonpruritic.

Urticarial Vasculitis

This condition is rare and is probably related to circulating immune complexes.

  • Persistent hive-like lesions last more than 24 hours.

  • Lesions may be tender rather than itchy.

  • Residual purpura or hyperpigmentation often ensues on resolution of lesions.

  • Evidence of vasculitis (e.g., purpura) is occasionally seen in the lesions.

  • The diagnosis is confirmed by skin biopsy.

  • Patients may have hypocomplementemia and an elevated erythrocyte sedimentation rate.

  • Urticarial vasculitis may be associated with collagen vascular diseases.

Management-icon.jpg Management

  • If possible, the cause of the hives should be eliminated, and tight clothing and hot baths and showers should be avoided, particularly in people who have a physical urticaria.

  • Salicylates, NSAIDs, and narcotics, which are all histamine-releasing agents, may aggravate both acute and chronic urticaria and should be avoided.

  • In 85% to 90% of patients with chronic urticaria, the origin remains unknown.

  • Anti-histamines are used to control and/or prevent hives and alleviate symptoms.

  • First-generation antihistamines are histamine receptor 1 (H1) blockers and include hydroxyzine (Atarax), diphenhydramine (Benadryl), and cyproheptadine (Periactin). These are usually sedating.

  • H1 and H2 blockers may be used in combination, such as cimetidine (Tagamet) plus hydroxyzine.

  • Nonsedating antihistamines, such as loratadine (Claritin) 10 mg, desloratadine (Clarinex) 5 mg, fexofenadine (Allegra) 60/180 mg, and cetirizine (Zyrtec) 10 mg, may be used during the day, and a more sedating H1 blocker or a tricyclic antidepressant drug, such as doxepin (Sinequan), may be tried at bedtime. Doxepin can be given at much lower doses than when it is used as an antidepressant (e.g., from 5 mg two times daily to 50 mg three times daily).

  • For problems at bedtime, a sedating antihistamine such as diphenhydramine or hydroxyzine may be added.

  • Patients with chronic urticaria often require much higher than the usual doses of antihistamines.

  • Systemic steroids are sometimes used for short periods to break the cycle of chronic urticaria; however, they are not indicated for long-term use in the treatment of chronic idiopathic urticaria.

  • Montelukast (Singulair), a leukotriene receptor antagonist used to treat asthma, has been found to be effective in some cases of CIU that are refractory to antihistamines.

  • Immunotherapies using prednisone, plasmapheresis, intravenous immunoglobulin, low-dose methotrexate, oral psoralens plus ultraviolet A treatment, oral tacrolimus, azathioprine, and cyclosporine have been used in severe, recalcitrant cases.

  • There have been some encouraging outcomes with the administration of the monoclonal antibody omalizumab (Xolair), a drug used for asthma, in the treatment of CIU.

  • If all else fails, a diary of daily foods eaten may be kept, with subsequent food elimination; however, this approach is rarely successful.

Helpful-Hint-icon.jpg Helpful Hints

  • Epinephrine, which is often administered by intramuscular or subcutaneous injection for acute urticaria, should not be used for routine cases of hives. It should be reserved for cases of acute anaphylaxis.

  • For the treatment of anaphylaxis, an EpiPen is a device that contains a spring-loaded needle that penetrates the recipient's skin, to deliver a predetermined dose of epinephrine via subcutaneous or intramuscular injection.

  • Patients with documented cold urticaria should be advised not to immerse themselves abruptly in cold water.

  • Children with chronic urticaria occasionally have an underlying autoimmune disease; thyroid antibodies are the most common positive finding.

  • Most cases of CIU resolve with or without treatment; on average: 50% are free of hives after 3 to 12 months; 20% are free of hives after 12 to 36 months, and 20% are free of hives after 36 to 60 months.

  • In some patients, hives may recur for many years.

Point-Remember-icon.jpg Points to Remember

  • Except for a physical urticaria and urticaria that is obviously associated with drugs and systemic disease, determining the cause of chronic urticaria is generally a fruitless task.

  • Most often, routine blood tests are of little or no value in determining the cause of acute or chronic urticaria.

  • Antihistamines remain the mainstay for treating chronic urticaria; a combination of these agents may be necessary for control.

  • Allergies are almost never the cause of chronic urticaria. Allergy testing is expensive and often tests that are positive for allergies have no relation to the patient's urticaria.

  • When individual wheals persist for more than 24 to 36 hours, the process is unlikely to be urticaria.

SEE PATIENT HANDOUT “Hives (Urticaria)” IN THE COMPANION eBOOK EDITION.

Other Information

Acute Urticaria !!navigator!!

Chronic Urticaria !!navigator!!

Dermatographism (“Skin Writing”) !!navigator!!

Cold Urticaria !!navigator!!

Light-Induced (Solar) Urticaria !!navigator!!

Cholinergic Urticaria !!navigator!!


Outline